期刊文献+

腺苷及其受体对肺保护的研究进展 被引量:1

Study Progresses of Adenosine and its Receptor in Lung Protection
下载PDF
导出
摘要 体外循环及肺移植所引起的肺损伤的发生机制尚未完全阐明,可能与多种因素有关,其中中性粒细胞和巨噬细胞等炎性细胞的激活、肺缺血再灌注损伤为主要的影响肺功能的因素。近年来,动物实验和临床研究发现,腺苷及腺苷受体在肺保护方面有重要作用。通过刺激A2、A3腺苷受体及其信号转导通路,可以抑制中性粒细胞等炎性细胞的激活,减轻肺的缺血再灌注损伤等,文章就这些方面的最新进展做一综述。 The mechanisms of hmg injury caused by extracorporeal circulation and hmg transplan- tation still is not illuminated completely, which maybe related to many factors, especially activation of inflammatory cells including neutmphil, macrophage and so on and lung ischenncal reperfuslon injury are the main factors affecting lung function. Recently, animal experiments and clinical researches sug- gested that adenosine and its receptors play a major role in lung protection. Stimulation of Signal trans- duction pathway of A2 or A3 adenosine receptors can attenuate hmg ischemical reperfusion injury and inhibit neutrophil activation and so on, This article reviews some progresses in these directions.
作者 段欣 王胜利
出处 《医学综述》 2007年第24期1944-1945,共2页 Medical Recapitulate
关键词 腺苷 缺血再灌注损伤 腺苷受体 Adenosine Lung ischemical reperfusion injury Adenosine receptors
  • 相关文献

参考文献19

  • 1Ely SW, Mentzer RM, Laslay RD, et al. Functional and metabolic evidence of enhanced myocardial tolerance toischemia and reperfusion with adenosine[ J ]. J Thorac Cardiovasc Surg, 1985,90(4) : 549-556.
  • 2Fredholm BB. Purines and neutrophil leukocytes [ J]. Gen Pharmacol, 1997,28 ( 3 ) : 345-350.
  • 3Murphree LJ, Sullivan GW, Marshall MA, et al. Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A (2A) adenosine receptor induction[ J ]. Biochem J, 2005,391 (Pt 3) : 575-580.
  • 4kappas CM, Rieger JM, Linden J. A2a adenosine receptor induction inhibits IFN-gamma production in murine CD4^+ T cells[J]. J Immunol, 2005,174(2) : 1073-1080.
  • 5Wollner A, Wollner S, Smith JB. Acting via A2 receptors adenosine inhibits the upregulation of Mac-1 ( CD11 b/CD18 ) expression on fMLP stimulated neutrophils [ J ]. Am J Respir Cell Mol Biol, 1993,9 (2) : 179-185.
  • 6Hannon JP, Bray-French KM, Phillips RM, et al. Further phamlacological characterization of the adenosine receplor subtype medialing inhibition of oxidative burst in isolated human neutrophils[J]. Drug Dev Res, 1998,43(4) :214-224.
  • 7Bouma MG, Stad RK, van den Wildenberg F, et al. Differential regulatory effects of adenosine on cytokine release by activated human monocytes[ J] .J Immunol, 1994, 153(9) :4159-4168.
  • 8Fiser SM,Tribble CG, Kaza AK, et al. Adenosine A2a receptor activation decreases reperfusion injury associated with high-flow reperfusion [J]. J Thorac Cardiovasc Surg,2002,124(5) :973-978.
  • 9Reece TB, Elhnan PI, Maxey TS, et al. Adenosine A2a receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation[ J ]. J Thorac Cardiovasc Surg, 2005, 129(5) : 1137-1143.
  • 10Sands WA, Martin AF, Strong EW, et al. Specific inhibition of nuclear faclor-kappaB-dependenl inflammatory responses by cell type-specific mechanisms upon A2, adenosine receplor gene transfer[ J ]. Mol Pharmacol, 2004,66(5) : 1147-1159.

二级参考文献18

  • 1[1]Murry CE,Jennings RB,Reimer KA.Preconditioning with ischemia:a delay of lethal cell injury in ischemia myocardium[J]. Circulation,1986,74:1124~1136.
  • 2[2]Baikhy HH,Peterson MB,Connoliy RJ,et al. Comparison of neurocollins and university of wisconsin solution in single flush presevation of the ischemia reperfused lung:an in vivo rabbit model[J]. Transplantation,1995,59:1090~1095.
  • 3[3]Wagner DR, Mctiernan C,Sandery VJ,et al. Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-alpha[J]. Circulation,1998,97:521~524.
  • 4[4]Jordan JE, Thourani VH, Auchampach JA, et al. A(3) adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury [J]. Am J Physiol,1999,277:1895~2800.
  • 5[5]Vthoffk, Zehr KJ,Lee PC, et al. Neutrophil modulation results in improved pulmonary function after 12 and 24 hours of preservation[J]. Ann Thorac Surg,1995,59:7~13.
  • 6[6]Visentin S,Wu SN,Belardinelli L. Adenosine-induced changes in atrial action potential:contribution of Ca2+and K+currents[J]. Am J Physiol, 1990,258:1070.
  • 7[7]Bouchard JF,Lamintagne D.Mechanisms of protection afforded by preconditioning to endothelial function against ischemia injury[J]. Am J Physiol,1996,271:H1801.
  • 8[8]Schmid RA,Yamashita M,Ando K,et al. Lidocaine reduces reperfusion injury and neutrophil migration in canine lung allografts[J]. Ann Thorac Surg, 1996,61:949~955.
  • 9[9]Crostein BN,Levin RI,Belanoff J,et al. Adenosine:an endogenous inhibitor of neutrophil mediated injury to endothelial cells[J]. J Clin Invest, 1986,78:760~770.
  • 10[10]McGowan FX Jr, Ikegami M,Del Midops, et al. Cardiopulmonary bypass significantly reduce surfactant activity in children[J]. J Thorac Cardiovasc Surg, 1993,106(6):968~977.

共引文献8

同被引文献16

  • 1李琳,秦建伟,邵永丰,张憬,梁永年,陈宇,李芝.腺苷与双嘧达莫预适应在心肺转流中的心肌保护作用[J].江苏医药,2007,33(7):669-671. 被引量:4
  • 2中国网.治疗ASC患者的新选择-倍林达中国上市获批准[EB/OL].http://www.chinadaily.com.cn/hqcj/2012-11/30/content_15975879.htm.2012-11-30,2013-00-10.
  • 3Wallentin L,Becker RC,Budaj A,et al.The PLATO Investigators.Ticagrelor versus clopidogrel in patients with acute coronary syndromes[J].N Engl J Med,2009,361(11):1045-1057.
  • 4Storey RF,Becker RC,Harrington RA,et al.Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes[J].Eur Heart J,2011,32(23):2945-2953.
  • 5Storey R,Bliden KP,Patil SB,et al.Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor,clopidogrel,or placebo in the ONSET/OFFSET study[J].J Am Coll Cardiol,2010,56(3):185-193.
  • 6Belchikov YG,Koenig SJ,Dipasquale EM.Potential role of endogenous adenosine in ticagrelor-induced dyspnea[J].Pharmacotherapy,2013,33(8):882-887.
  • 7Butler K,Maya J,Teng R.Effect of ticagrelor on pulmonary function in healthy elderly volunteers and asthma or chronic obstructive pulmonary disease patients[J].Current Medical Research and Opinion,2013,29(5):569-577.
  • 8Ohman J,Kudira R,Albinsson S,et al.Ticagrelor induces adenosine triphosphate release from human red blood cells[J].Biochem Biophys Res Commun,2012,418(4):754-761.
  • 9Parshall MB,Schwartzstein RM,Adams L,et al.An official American Thoracic Society statement:update on the mechanisms,assessment,and management of dyspnea[J].Am J Respir Crit Care Med,2012,185(4):435-487.
  • 10Cattaneo M,Faioni EM.Why does ticagrelor induce dyspnea[J].=Thromb Haemost,2012,108(6):1031-1036.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部